medicare coverage glp-1 drugs Majesta GLP-1 Drugs & Medicare in

J Diabetes Res 2019(9426014)

GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro were initially developed to treat type 2 diabetes, but their effectiveness as anti-obesity medications has generated tremendous excitement and high demand among people who have struggled to lose weight by other means

Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2022

It has been shown from several studies that at least 5% of the initial body weight is required for the improvement of the hepatic steatosis [7]

Weghuber D, Barrett T, Barrientos-Perez M, Gies I, Hesse D, Jeppesen OK, et al

GLP-1 receptor agonists are synthetic molecules that mimic the action of endogenous GLP-1 with significantly extended half-lives, enabling sustained metabolic effects